Comparison of Long-Term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis Between Dupilumab-Exposed and Dupilumab-Naïve Patients

ConclusionsThis study confirmed the clinical effectiveness of upadacitinib treatment in adult patients in a real-world setting with moderate-to-severe AD who had discontinued dupilumab due to poor effectiveness or adverse events and who were biologic na ïve; therefore, previous treatments do not seem to affect the response to upadacitinib treatment.

http://link.springer.com/10.1007/s40261-023-01336-w

Source: Clinical Drug Investigation - December 17, 2023 Category: Drugs & Pharmacology Source Type: research